CarryGenes jobs and careers

About CarryGenes

The next major breakthrough in Immuno-oncology With a proprietary human synthetic chromosome (hSynC) as a carrier for antitumoral factors (OncoSynC) introduced into the patient’s own T-cells, CarryGenes’ Cromo-T will create a state of long-term vaccination against the patient’s tumor using immune cells loaded with an enhanced tumor-killing capacity. With a passion for science CarryGenes merges technologies as well as expertise in immunotherapy and chromosome bioengineering to produce a novel therapeutic with advanced safety mechanisms With a lifelong passion for science and improving human health, the team has a joint ambition to use their knowledge to improve human health. Today there are no similar solutions to fight cancer.

Founded in 2018 by Amy Greene, Edward Perkins, Lennart Dreyer and Ola Winqvist.